title: "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.
abstract: One problem of conventional allergen-specific immunotherapy is the risk of anaphylactic reactions. A new approach to make immunotherapy safer and more efficient might be the application of engineered allergens with reduced IgE-binding capacity but retained T cell reactivity. Using overlapping dodeca-peptides, the dominant T cell epitopes of the timothy grass pollen allergen Phl p 5b were identified. By site-directed mutagenesis outside these regions, point and deletion mutants were generated. Allergen variants were analyzed for IgE-binding capacity with sera of different grass pollen allergic patients by Western blotting, Dot blotting, and EAST inhibition test, and for histamine releasing capacity with peripheral blood basophils from different patients. The deletion mutants revealed significantly reduced IgE reactivity and histamine releasing capacity, compared with the wild-type Phl p 5b. Furthermore, in vivo skin prick tests showed that the deletion mutants had a significantly lower potency to induce cutaneous reactions than the wild-type Phl p 5b. On the other hand, T cell clones and T cell lines from different allergic patients showed comparable proliferation after stimulation with allergen variants and wild-type Phl p 5b. Considering their reduced anaphylactogenic potential together with their conserved T cell reactivity, the engineered allergens could be important tools for efficient and safe allergen-specific immunotherapy.
authors.affiliation: Biochemische und Molekulare Allergologie, Forschungszentrum Borstel, Germany. gschramm@fz-borstel.de
authors.forename: G
authors.initials: G
authors.lastname: Schramm
authors.forename: H
authors.initials: H
authors.lastname: Kahlert
authors.forename: R
authors.initials: R
authors.lastname: Suck
authors.forename: B
authors.initials: B
authors.lastname: Weber
authors.forename: H T
authors.initials: HT
authors.lastname: Stüwe
authors.forename: W D
authors.initials: WD
authors.lastname: Müller
authors.forename: A
authors.initials: A
authors.lastname: Bufe
authors.forename: W M
authors.initials: WM
authors.lastname: Becker
authors.forename: M W
authors.initials: MW
authors.lastname: Schlaak
authors.forename: L
authors.initials: L
authors.lastname: Jäger
authors.forename: O
authors.initials: O
authors.lastname: Cromwell
authors.forename: H
authors.initials: H
authors.lastname: Fiebig
mesh_terms: D000485:Allergens / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D001666:Binding Sites, Antibody; D002460:Cell Line; D002999:Clone Cells; D018604:Epitope Mapping; D014644:Genetic Variation / Q000276:immunology; D006636:Histamine Release / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000378:metabolism*; D010940:Plant Proteins / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006109:Poaceae / Q000276:immunology; D011058:Pollen / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D015202:Protein Engineering / Q000379:methods*; D012882:Skin Tests; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism